Results 91 to 100 of about 40,271 (232)

Acute Urinary Retention Following Low-Dose Risperidone in a Young Woman: A Case Report

Case Reports in Psychiatry
Risperidone is a widely used antipsychotic for psychotic disorders and is also used as an adjunctive treatment for many psychiatric conditions. While acute urinary retention is more commonly associated with antipsychotics that have anticholinergic ...
Obada Zain, Mhd Omar Iyoun, Jana Ebido, Salma Khadem Alsrouji, Youssef Latifeh   +4 more
doaj   +1 more source

Different effects of social cognitive skills training in schizophrenia and autism spectrum disorder: A rater‐blinded, multicenter, randomized controlled trial

Psychiatry and Clinical Neurosciences, EarlyView.
Aim Schizophrenia (SCZ) and autism spectrum disorder (ASD) are both characterized by social cognitive impairments that strongly predict poor functional outcomes. However, evidence‐based social cognitive interventions have been developed only for SCZ.
Sadao Otsuka, Satsuki Oe, Sumie Yamada, Haruka Kumoi, Ryoichi Suwabe, Tatsuro Iwane, Kosuke Tsurumi, Toshiya Murai   +7 more
wiley   +1 more source

Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure

Pakistan Journal of Pharmaceutical Sciences
Background: Long-term use of antipsychotics like risperidone raises metabolic syndrome (MetS) risk, with evidence from Chinese populations being limited. Objectives: This study compared MetS prevalence and metabolic profiles between chronic schizophrenia
Yimin Wu, Jie Wu, Zuobin Deng, Tao Xiao
doaj   +1 more source

Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard, Florian Stéphan, Boris Chaumette, Mathilde Moreau, Laure Bleton, Nicolas Hornez, Steeve Genestet, Jérémy Betrand, Amélie Bourhis, Morgane Le Bon‐Jégo, Thierry Bienvenu, Camille Verebi, Laurent Misery   +12 more
wiley   +1 more source

Of mice and men—The emerging oral–gut–brain axis of health and disease

Periodontology 2000, EarlyView.
Abstract Objectives Oral health's inextricable links to systemic health are highlighted by the emerging oral–gut–brain axis and other well‐known axes. There is growing evidence of a complex oral–gut–brain axis linking mouth and gut microbiomes with the central nervous system.
Yvonne L. Hernandez‐Kapila, Daniel J. Weisenberger   +1 more
wiley   +1 more source

An investigation into the underlying mechanisms of risperidone-induced antinociception through the cholinergic pathway

Pharmaceutical Science Advances
Pain is a complex phenomenon involving the perception of physical discomfort caused by tissue damage in the body. Risperidone, a neuroleptic with dopamine (D2) and serotonin (5-HT2) receptor antagonistic potentials, also exhibits antinociceptive ...
Lawrence Adedayo, Victor Adesoye, Olubayode Bamidele, Idris Azeez, Oyetola Oyebanjo, Adeshina Adekeye, Saminu Samaila, Nimedia Aitokhuehi, Olusegun Adebayo, Gideon Ojo   +9 more
doaj   +1 more source

Design Considerations for Polymer–Deep Eutectic Solvent Hybrid Systems for Transdermal Drug Delivery

Journal of Applied Polymer Science, Volume 143, Issue 40, October 20, 2026.
Deep eutectic solvents (DESs) act as tunable, green excipients that modulate polymer structure–property relationships to enhance drug solubility, skin permeation, stability, and controlled release. Through hydrogen‐bond interactions, DES–polymer hybrid systems enable improved transdermal performance, offering a rational, design‐driven platform for ...
Madhavi Kailas Kapale, Madhur Kulkarni, Pranav J. Shah, Furqan A. Maulvi   +3 more
wiley   +1 more source

Risperidone-ISM

To evaluate the effectiveness, time to discharge, functioning, and tolerability of Risperidone-ISM in hospitalised patients with schizophrenia relapse.
Correll, Christoph U, Bioque, Miquel, Madeira, Nuno, Dratcu, Luiz, Gahr, Maximilian, Bernardo, Miquel, Núñez Sande, Carmen, Göldner, Randi Susanne, Langner-Timm, Steffi, Anta Carabias, Lourdes, Heres, Stephan, Pappa, Sofia, Landry, Christopher, Rohner, Henrik, Gago, Joaquim, Maina, Giuseppe, Dimalta, Savino, De Giorgi, Serafino, Martínez-González, Javier, Vita, Antonio, Falkai, Peter, Vieira Coelho, María Augusta, Sánchez-García, Sheila, Caballero, Montserrat, Rodriguez-Jimenez, Roberto, González-Pinto, Ana, Molina, Rosa, Assion, Hans-Jörg, Farooq, Saeed, Schöttle, Daniel, Fernández-Egea, Emilio, Messer, Thomas   +31 more
core   +1 more source

Antipsychotic Drug Interactions and Short‐Term Mortality Risk in People With Dementia: A National Cohort Study

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 1081-1091, October 2026.
Antipsychotics are often prescribed in the management of behaviors and psychological symptoms of dementia. While the potential harms of antipsychotic use in people with dementia have been established, little is known about the risk associated with antipsychotic drug–drug interactions (DDIs). This study aims to examine the patterns of antipsychotic DDIs
Edward C.Y. Lau, Grace H. Shim, Chin Hang Yiu, Sarah N. Hilmer, Yun‐Hee Jeon, Weisi Chen, Christine Y. Lu, Edwin C.K. Tan   +7 more
wiley   +1 more source

Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm

British Journal of Pharmacology, Volume 183, Issue 19, Page 5701-5731, October 2026.
Abstract Antipsychotic drugs targeting dopamine receptors have been used to treat schizophrenia for decades, primarily alleviating positive symptoms such as hallucinations and delusions. However, they provide limited benefit for cognitive and negative symptoms—major contributors to poor outcomes—and are frequently associated with significant side ...
Brian J. Morris, Judith A. Pratt
wiley   +1 more source